Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Celularity Inc incurred loan of $3.0 million with Dr. Robert Hariri and two unaffiliated lenders at 15% per year maturing August 21, 2024.
- Instrument
- loan
- Principal
- $3.0 million
- Counterparty
- Dr. Robert Hariri and two unaffiliated lenders
- Rate
- 15% per year
- Maturity
- August 21, 2024
- Event
- incurrence
Exact text from the filing
On August 21, 2023, Celularity Inc., or Celularity, entered into a Loan Agreement with its Chairman and Chief Executive Officer, Dr. Robert Hariri, and two unaffiliated lenders, providing for a loan in the aggregate principal amount of $3.0 million (of which Dr. Hariri contributed $1.0 million), or the Loan.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Celularity Inc entered into Loan Agreement with Dr. Robert Hariri and two unaffiliated lenders valued at $3.0 million (effective 2023-08-21).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- Dr. Robert Hariri and two unaffiliated lenders
- Value
- $3.0 million
- Effective
- 2023-08-21
Exact text from the filing
On August 21, 2023, Celularity Inc., or Celularity, entered into a Loan Agreement with its Chairman and Chief Executive Officer, Dr. Robert Hariri, and two unaffiliated lenders, providing for a loan in the aggregate principal amount of $3.0 million
View on SEC.gov